• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On GLAXO.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    GlaxoSmithkline Pharmaceuticals Limited (GLAXO.NS)

    -NSE
    3,285.20 Up 11.05(0.34%) 5:59AM EDT
    Add to Portfolio
    Prev Close:3,274.15
    Open:3,300.00
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3,269.95 - 3,348.95
    52wk Range:2,365.00 - 3,550.00
    Volume:17,151
    Avg Vol (3m):15,497
    Market Cap:278.27B
    P/E (ttm):57.77
    EPS (ttm):56.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):46.10
    P/S (ttm):10.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :65.85
    Quarterly EPS Est (Sep-14) :N/A
    Mean Recommendation*:3.1
    PEG Ratio (5 yr expected):2.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infecti... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback